Altizon Launches APEX Alliance — Altizon Partner EXcellence Alliance — to Accelerate Industrial AI on Microsoft Azure
PRINCETON, N.J., July 30, 2025 /PRNewswire/ -- Altizon...
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- The meme-powered crypto project Troller Cat ($TCAT) has entered the 15th and final stages of its presale, raising more than $425,000 and attracting over 1,600 token holders to date. With a listing price set at $0.0005309, Stage 15 tokens are currently available at $0.0001063, offering a potential value gap that has contributed to renewed market interest.
SYDNEY, July 30, 2025 /PRNewswire/ -- FranklinWH Australia Pty Ltd. (FranklinWH Australia), a leading global provider of home energy management and storage systems, is officially approved...
Second Quarter 2025 Financial Highlights
Revenue of $174 million increased 11% sequentiallyNet income before taxes of $19.4 million increased $14.4 million sequentiallyAdjusted EBITDA of $35.9...
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- MoonBull ($MOBU), an Ethereum-based meme coin project, has officially opened its whitelist registration phase. This early-access window allows selected participants to secure priority entry ahead of MoonBull’s upcoming presale launch, which is expected to begin in the coming weeks.
Net income available to common stockholders of $5.5 million and $48.0 million for the three and six months ended June 30, 2025, respectively, or $0.09 and $0.79 per diluted share, respectively.
NEW YORK, July 29, 2025 /PRNewswire/ -- Improved systems and practices could cut landfill methane emissions in half while generating revenue for operators, a report released...
BEIJING, China, July 29, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today officially launched Li i8, a six-seat battery electric family SUV. As an SUV of the new era, Li i8 combines the all-terrain capabilities of off-road vehicles, the handling dynamics of sedans, and the comfort of MPVs, redefining family mobility with an all-new driving and riding experience.
Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.